Skip to Main Content

Author Details

Jonine D Figueroa
The Usher Institute, The University of Edinburgh
2001
243
65
PMIDPaper TitleJournal TitlePublished Year
34992224Relation of circulating estrogens with hair relaxer and skin lightener use among postmenopausal women in Ghana.J Expo Sci Environ Epidemiol2023
38082317Mosquito control exposures and breast cancer risk: analysis of 1071 cases and 2096 controls from the Ghana Breast Health Study.Breast Cancer Res2023
37789226Polymorphisms in genes of melatonin biosynthesis and signaling support the light-at-night hypothesis for breast cancer.Eur J Epidemiol2023
37784154Evaluation of the association of area-level socioeconomic deprivation and breast cancer recurrence by oestrogen receptor subtypes in Scotland.Breast Cancer Res2023
37698273A rapid review of COVID-19's global impact on breast cancer screening participation rates and volumes from January to December 2020.Elife2023
37341612Associations of Circulating Estrogens and Estrogen Metabolites with Fecal and Oral Microbiome in Postmenopausal Women in the Ghana Breast Health Study.Microbiol Spectr2023
37090574Associations of breast cancer etiologic factors with stromal microenvironment of primary invasive breast cancers in the Ghana Breast Health Study.Res Sq2023
37210288Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights.Eur Urol2023
36824750Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.Res Sq2023
36707629FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women.Eur J Hum Genet2023
36882607Adaptive immune receptor features related to breast cancer tissue in Kenyan patients: high immunoglobulin gene expression and high levels of gamma-delta T-cells.Breast Cancer Res Treat2023
34992224Relation of circulating estrogens with hair relaxer and skin lightener use among postmenopausal women in Ghana.J Expo Sci Environ Epidemiol2023
35094015Correction to: Relation of circulating estrogens with hair relaxer and skin lightener use among postmenopausal women in Ghana.J Expo Sci Environ Epidemiol2023
38082317Mosquito control exposures and breast cancer risk: analysis of 1071 cases and 2096 controls from the Ghana Breast Health Study.Breast Cancer Res2023
37789226Polymorphisms in genes of melatonin biosynthesis and signaling support the light-at-night hypothesis for breast cancer.Eur J Epidemiol2023
37698273A rapid review of COVID-19's global impact on breast cancer screening participation rates and volumes from January to December 2020.Elife2023
37784154Evaluation of the association of area-level socioeconomic deprivation and breast cancer recurrence by oestrogen receptor subtypes in Scotland.Breast Cancer Res2023
37090574Associations of breast cancer etiologic factors with stromal microenvironment of primary invasive breast cancers in the Ghana Breast Health Study.Res Sq2023
37210288Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights.Eur Urol2023
37341612Associations of Circulating Estrogens and Estrogen Metabolites with Fecal and Oral Microbiome in Postmenopausal Women in the Ghana Breast Health Study.Microbiol Spectr2023
36882607Adaptive immune receptor features related to breast cancer tissue in Kenyan patients: high immunoglobulin gene expression and high levels of gamma-delta T-cells.Breast Cancer Res Treat2023
36707629FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women.Eur J Hum Genet2023
36824750Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.Res Sq2023
35094015Correction to: Relation of circulating estrogens with hair relaxer and skin lightener use among postmenopausal women in Ghana.J Expo Sci Environ Epidemiol2023
35081987Measured body size and serum estrogen metabolism in postmenopausal women: the Ghana Breast Health Study.Breast Cancer Res2022
35657343The oral microbiome and breast cancer and nonmalignant breast disease, and its relationship with the fecal microbiome in the Ghana Breast Health Study.Int J Cancer2022
35654374Breast Cancer Risk in Women from Ghana Carrying Rare Germline Pathogenic Mutations.Cancer Epidemiol Biomarkers Prev2022
36303815A genome-wide gene-based gene-environment interaction study of breast cancer in more than 90,000 women.Cancer Res Commun2022
35585550Breast cancer risks associated with missense variants in breast cancer susceptibility genes.Genome Med2022
35648299Breast cancer incidence and survival in Scotland by socio-economic deprivation and tumour subtype.Breast Cancer Res Treat2022
35554533Polygenic risk scores for prediction of breast cancer risk in women of African ancestry: a cross-ancestry approach.Hum Mol Genet2022
36271417PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~â¿¿200,000 patients.Breast Cancer Res2022
35933885Incorporating progesterone receptor expression into the PREDICT breast prognostic model.Eur J Cancer2022
35418701Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women.Sci Rep2022
35723569Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes: Pooled Analysis of Population-Based Studies.J Natl Cancer Inst2022
36419099Correction: PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated inâ¿¿~â¿¿200,000 patients.Breast Cancer Res2022
36116093Reproductive history differs by molecular subtypes of breast cancer among women aged⿿⿤⿿50 years in Scotland diagnosed 2009-2016: a cross-sectional study.Breast Cancer Res Treat2022
35333343Association of Genetic Ancestry With Terminal Duct Lobular Unit Involution Among Healthy Women.J Natl Cancer Inst2022
35042965Rare germline copy number variants (CNVs) and breast cancer risk.Commun Biol2022
35084436Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes.JAMA Oncol2022
35081987Measured body size and serum estrogen metabolism in postmenopausal women: the Ghana Breast Health Study.Breast Cancer Res2022
35654374Breast Cancer Risk in Women from Ghana Carrying Rare Germline Pathogenic Mutations.Cancer Epidemiol Biomarkers Prev2022
35585550Breast cancer risks associated with missense variants in breast cancer susceptibility genes.Genome Med2022
35648299Breast cancer incidence and survival in Scotland by socio-economic deprivation and tumour subtype.Breast Cancer Res Treat2022
35723569Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes: Pooled Analysis of Population-Based Studies.J Natl Cancer Inst2022
35418701Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women.Sci Rep2022
35657343The oral microbiome and breast cancer and nonmalignant breast disease, and its relationship with the fecal microbiome in the Ghana Breast Health Study.Int J Cancer2022
35554533Polygenic risk scores for prediction of breast cancer risk in women of African ancestry: a cross-ancestry approach.Hum Mol Genet2022
36419099Correction: PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated inâ¿¿~â¿¿200,000 patients.Breast Cancer Res2022
35933885Incorporating progesterone receptor expression into the PREDICT breast prognostic model.Eur J Cancer2022
  • 1 - 50 of 486

Recommended Authors

University of Washington
Career Start Year 2014
Number of shared co-authors 19
Netherlands Cancer Institute
Career Start Year 2012
Number of shared co-authors 24
Indiana University School of Medicine
Career Start Year 2011
Number of shared co-authors 0
Queen Mary Universityof London
Career Start Year 2010
Number of shared co-authors 2
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 25
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 44
Clinical Investigations Branch, National Cancer Institute
Career Start Year 2004
Number of shared co-authors 25
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 19
King Edward Memorial Hospital
Career Start Year 2002
Number of shared co-authors 0
The First Hospital of Lanzhou University
Career Start Year 2002
Number of shared co-authors 3
Olivia Newton-John Cancer Research Institute
Career Start Year 2002
Number of shared co-authors 1
Department of Medicine and Moores Cancer Center, University of California San Diego
Career Start Year 2000
Number of shared co-authors 4
Familial Cancer Clinic, Hospital Sant Pau
Career Start Year 2000
Number of shared co-authors 87
University of Cambridge
Career Start Year 2000
Number of shared co-authors 24
University of Oslo
Career Start Year 1997
Number of shared co-authors 12
Dana Farber Cancer Institute.
Career Start Year 1997
Number of shared co-authors 22
Karolinska Institutet
Career Start Year 1997
Number of shared co-authors 3
Institute of Health Policy, Dalla Lana School of Public Health, University of Toronto
Career Start Year 1996
Number of shared co-authors 18
University Health Network
Career Start Year 1994
Number of shared co-authors 6
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 5
European Translational Oncology Prevention and Screening (EUTOPS) Institute
Career Start Year 1993
Number of shared co-authors 78
The University of Texas MD Anderson Cancer Center
Career Start Year 1993
Number of shared co-authors 11
Fred Hutchinson Cancer Research Center
Career Start Year 1991
Number of shared co-authors 11
Princess Margaret Cancer Centre
Career Start Year 1991
Number of shared co-authors 20
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 3
Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania
Career Start Year 1988
Number of shared co-authors 67
Karolinska Institute
Career Start Year 1988
Number of shared co-authors 33
German Cancer Research Center (DKFZ)
Career Start Year 1985
Number of shared co-authors 121
University of California los angeles
Career Start Year 1970
Number of shared co-authors 43

Collaborators

National Cancer Institute
Co-authored papers 173
University of Cambridge
Co-authored papers 107
National Cancer Institute, National Institutes of Health
Co-authored papers 103
German Cancer Research Center (DKFZ)
Co-authored papers 101
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 101
Co-authored papers 99
Co-authored papers 96
Co-authored papers 92
Otto-Friedrich-University Bamberg
Co-authored papers 90
Mayo Clinic
Co-authored papers 89
University of Southern California
Co-authored papers 87
University of Toronto
Co-authored papers 87
Co-authored papers 84
Instituto de Salud Carlos III
Co-authored papers 75
QIMR Berghofer Medical Research Institute
Co-authored papers 75
The M. Sklodowska-Curie Cancer Center and Institute of Oncology
Co-authored papers 71
Pomeranian Medical University
Co-authored papers 71
Co-authored papers 70
National Cancer Institute
Co-authored papers 65
Faculty of Clinical Medicine, University of Oslo
Co-authored papers 64
University of California irvine
Co-authored papers 63
Co-authored papers 63
Mayo Clinic
Co-authored papers 59
Co-authored papers 59
Ospedale Circolo e Fondazione Macchi
Co-authored papers 57
Mayo Clinic
Co-authored papers 56
Co-authored papers 54
The Kolling Institute, University of Sydney, and Royal North Shore Hospital
Co-authored papers 51
Co-authored papers 49
Erasmus Medical Center
Co-authored papers 49